Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) CEO Peter Salzmann sold 3,233 shares of the business’s stock in a transaction dated Wednesday, July 12th. The shares were sold at an average price of $19.73, for a total value of $63,787.09. Following the sale, the chief executive officer now directly owns 1,231,136 shares of the company’s […]

Related Keywords

United States , America , Stifel Nicolaus , Peter Salzmann , Securities Exchange Commission , Immunovant Inc , Denali Advisors , Ensign Peak Advisors Inc , Immunovant Company Profile , Nasdaq , Get Free Report , Exchange Commission , Peak Advisors Inc , Chardan Capital , Immunovant Daily , Immunovant , Nasdaq Imvt , Imvt , Medical , Insider Trading , Nsider Trades , Tocks ,